Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 375.7	$ 378.1
Accounts receivable, less allowance for credit losses	1,381.5	1,259.6
Inventories	2,147.2	2,148.0
Prepaid taxes	198.4	326.7
Prepaid expenses and other current assets	324.5	271.0
Current assets of discontinued operations		501.6
Total Current Assets	4,427.3	4,885.0
Property, plant and equipment, net	1,872.5	1,836.6
Goodwill	8,580.2	8,919.4
Intangible assets, net	5,063.8	5,533.6
Other assets	1,122.2	1,005.0
Noncurrent assets of discontinued operations		1,276.8
Total Assets	21,066.0	23,456.4
Current Liabilities:
Accounts payable	354.1	306.5
Income taxes payable	38.5	62.0
Other current liabilities	1,421.3	1,317.1
Current portion of long-term debt	544.3	1,605.1
Current liabilities of discontinued operations		177.2
Total Current Liabilities	2,358.2	3,467.9
Deferred income taxes, net	474.8	558.5
Long-term income tax payable	421.2	583.0
Other long-term liabilities	632.6	548.5
Long-term debt	5,152.2	5,463.7
Noncurrent liabilities of discontinued operations		168.4
Total Liabilities	9,039.0	10,790.0
Commitments and Contingencies (Note 21)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized,313.8 million (312.8 million in 2021) issued	3.1	3.1
Paid-in capital	9,504.4	9,314.8
Retained earnings	9,559.3	10,292.2
Accumulated other comprehensive loss	(179.3)	(231.6)
Treasury stock, 104.8 million shares (103.8 million shares in 2021)	(6,867.2)	(6,717.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,020.3	12,660.7
Noncontrolling interest	6.7	5.7
Total Stockholders' Equity	12,027.0	12,666.4
Total Liabilities and Stockholders' Equity	$ 21,066.0	$ 23,456.4